Table of Contents

company-logo

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.

Protagenic Therapeutics Dividend Announcement

• Protagenic Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Protagenic Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Protagenic Therapeutics Dividend History

Protagenic Therapeutics Dividend Yield

Protagenic Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Protagenic Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Protagenic Therapeutics Financial Ratios

P/E ratio-0.52
PEG ratio0.00
P/B ratio4.07
ROE-308.96%
Payout ratio0.00%
Current ratio1.80
Quick ratio1.80
Cash Ratio1.34

Protagenic Therapeutics Dividend FAQ

Does Protagenic Therapeutics stock pay dividends?
Protagenic Therapeutics does not currently pay dividends to its shareholders.
Has Protagenic Therapeutics ever paid a dividend?
No, Protagenic Therapeutics has no a history of paying dividends to its shareholders. Protagenic Therapeutics is not known for its dividend payments.
Why doesn't Protagenic Therapeutics pay dividends?
There are several potential reasons why Protagenic Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Protagenic Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Protagenic Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Protagenic Therapeutics a dividend aristocrat?
Protagenic Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Protagenic Therapeutics a dividend king?
Protagenic Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Protagenic Therapeutics a dividend stock?
No, Protagenic Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Protagenic Therapeutics stocks?
To buy Protagenic Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Protagenic Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.